These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27244235)

  • 1. Ibogaine and addiction in the animal model, a systematic review and meta-analysis.
    Belgers M; Leenaars M; Homberg JR; Ritskes-Hoitinga M; Schellekens AF; Hooijmans CR
    Transl Psychiatry; 2016 May; 6(5):e826. PubMed ID: 27244235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature.
    Mosca A; Chiappini S; Miuli A; Mancusi G; Santovito MC; Di Carlo F; Pettorruso M; Corkery JM; Canessa C; Martinotti G; Di Giannantonio M
    Curr Neuropharmacol; 2023; 21(11):2178-2194. PubMed ID: 36263479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How toxic is ibogaine?
    Litjens RP; Brunt TM
    Clin Toxicol (Phila); 2016; 54(4):297-302. PubMed ID: 26807959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.
    Blackburn JR; Szumlinski KK
    Behav Brain Res; 1997 Dec; 89(1-2):99-106. PubMed ID: 9475618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of ibogaine on cocaine self-administration in rats.
    Cappendijk SL; Dzoljic MR
    Eur J Pharmacol; 1993 Sep; 241(2-3):261-5. PubMed ID: 8243561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Alkaloids Chem Biol; 2001; 56():39-53. PubMed ID: 11705115
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
    Glick SD; Maisonneuve IM; Pearl SM
    Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and aftereffects of ibogaine on morphine self-administration in rats.
    Glick SD; Rossman K; Steindorf S; Maisonneuve IM; Carlson JN
    Eur J Pharmacol; 1991 Apr; 195(3):341-5. PubMed ID: 1868880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.
    Koenig X; Kovar M; Boehm S; Sandtner W; Hilber K
    Addict Biol; 2014 Mar; 19(2):237-239. PubMed ID: 22458604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
    Mash DC
    Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 1997; 42(3):161-8. PubMed ID: 8995326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.
    Onaivi ES; Ali SF; Chirwa SS; Zwiller J; Thiriet N; Akinshola BE; Ishiguro H
    Ann N Y Acad Sci; 2002 Jun; 965():28-46. PubMed ID: 12105083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibogaine neurotoxicity: a re-evaluation.
    Molinari HH; Maisonneuve IM; Glick SD
    Brain Res; 1996 Oct; 737(1-2):255-62. PubMed ID: 8930373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.
    Rodríguez-Cano BJ; Kohek M; Ona G; Alcázar-Córcoles MÁ; Dos Santos RG; Hallak JEC; Bouso JC
    Drug Alcohol Rev; 2023 Feb; 42(2):401-414. PubMed ID: 36456173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents.
    Mash DC; Ameer B; Prou D; Howes JF; Maillet EL
    J Psychopharmacol; 2016 Jul; 30(7):688-97. PubMed ID: 27044509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats.
    Kesner RP; Jackson-Smith P; Henry C; Amann K
    Pharmacol Biochem Behav; 1995 May; 51(1):103-9. PubMed ID: 7617719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Rubi L; Eckert D; Boehm S; Hilber K; Koenig X
    Cardiovasc Toxicol; 2017 Apr; 17(2):215-218. PubMed ID: 27020671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic literature review of clinical trials and therapeutic applications of ibogaine.
    Köck P; Froelich K; Walter M; Lang U; Dürsteler KM
    J Subst Abuse Treat; 2022 Jul; 138():108717. PubMed ID: 35012793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.